Australia’s viral vector manufacturing capability is set to support the development of a novel gene therapy and light-based treatment approach for obstructive sleep apnoea under a new collaboration involving the Viral Vector Manufacturing Facility, Optosleep and UNSW Sydney. …
VVMF and Optosleep partner to advance Australian gene therapy for sleep apnoea
August 13, 2026 Latest NewsBioPharmaAustralian Biotech
Latest Video
New Stories
-
An institution dominated by very clever people, but where is the wisdom?
August 14, 2026 - - Latest News -
A plain language version of these dreadful and useless documents
August 14, 2026 - - Latest News -
Arcimedes raises oversubscribed seed round to scale healthcare AI
August 14, 2026 - - Latest News -
CUREator+ backs six Australian startups with $13.5 million to advance new health technologies
August 13, 2026 - - Australian Biotech -
Medicines Australia appoints former AbbVie executive to key leadership role
August 13, 2026 - - Latest News -
VVMF and Optosleep partner to advance Australian gene therapy for sleep apnoea
August 13, 2026 - - Latest News -
Survey exposes deep gaps in neurological care across Australia
August 13, 2026 - - Latest News